BIO has long supported responsible and ethical testing, protection of individual privacy and genetic information, and regulatory systems that best serve humanity and advance research into new treatments for patients, regardless of where research is conducted.
BIO is committed to the socially responsible use of biotechnology to save or improve lives, improve the quality and abundance of food, and protect our environment. Our board of directors has adopted a Statement of Ethical Principles, and we continue to refine a comprehensive vision of ways to ensure biotechnology is used for the betterment of humankind and not abused.
The public has a strong interest in protecting research and research participants. Federal policy must find the right balance in protecting participants while allowing critical research to continue.
Biotechnology is all around us and is already a big part of our lives, providing breakthrough products and technologies to combat disease, reduce our environmental footprint, feed the hungry, and make useful products.
Patient requests for access to drugs and biologics prior to their approval has long created a dilemma for biotechnology companies. This document provides "Points to Consider" for biotechnology companies confronting these issues.